Start Over


Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial

Site Image

Study Overview

If you tested positive for COVID-19 within the last 5 days, you may be eligible to participate in a research study to test the ability of a pill to reduce COVID-19 symptoms.

Study Description

What is the medication that is being tested?

The study medication is an antiviral pill that is designed to reduce symptoms of COVID-19

Is there payment for taking part in this study?
Participants who complete all expected parts of the study will earn $500

Am I eligible to join this study?
To find out and to learn more, please fill out the screening form below

__________________________________________________________

  • Study Identifier: 851173

Recruitment Status

Open

Check to see if you pre-qualify for the study.

Are you between the age of 18 and 64?
Back
Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu